{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:28:56Z","timestamp":1788571736782,"version":"build-2803163510"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Colchicin ist ein entz\u00fcndungshemmender pflanzlicher Arzneistoff mit einer jahrtausendealten Geschichte. Es wird seit jeher erfolgreich in der Akuttherapie und Prophylaxe der Gicht eingesetzt und konnte sich einen festen Platz im pharmakologischen Standardrepertoire bei famili\u00e4rem Mittelmeerfieber, Perikarditis, neutrophilen Dermatosen, Morbus Beh\u00e7et und oralen therapierefrakt\u00e4ren schweren Aphthosen sichern. Rezent hat die US-amerikanische Food and Drug Administration (FDA) Colchicin zugelassen, um das Risiko von Myokardinfarkt, Schlaganfall, koronarer Revaskularisation und kardiovaskul\u00e4rem Tod bei erwachsenen Patienten mit bestehender atherosklerotischer Erkrankung oder mit mehreren Risikofaktoren f\u00fcr eine kardiovaskul\u00e4re Erkrankung zu verringern. Der Empfehlungsgrad zur kardiovaskul\u00e4ren Prophylaxe wurde in den aktuellen ESC-Leitlinien von 2024 von IIb auf IIa angehoben. Klinische Studien der vergangenen Jahre belegen ferner einen Effekt beim akuten Koronarsyndrom und Vorhofflimmern. Diese \u00dcbersichtsarbeit beleuchtet das Wirksamkeits- und Sicherheitsprofil von Colchicin und bietet einen Einblick in rezente und m\u00f6gliche zuk\u00fcnftige evidenzbasierte Anwendungsgebiete.<\/jats:p>","DOI":"10.1007\/s00508-024-02490-7","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:47:07Z","timestamp":1738828027000},"page":"1-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Colchicin\u00a0\u2013 Ph\u00f6nix aus der Asche","Colchicine\u2014Phoenix from the ashes"],"prefix":"10.1007","volume":"137","author":[{"given":"Raimund","family":"Lunzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Delle-Karth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Maria","family":"Pracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"2490_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-98605-0","volume-title":"Textbook of Autoinflammation","author":"PJ Hashkes","year":"2019","unstructured":"Hashkes\u00a0PJ, Laxer\u00a0RM, Simon\u00a0A. Textbook of Autoinflammation. Basel: Springer International Publishing AG; 2019."},{"issue":"22","key":"2490_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/eurheartj\/ehx246","volume":"38","author":"A Bayes-Genis","year":"2017","unstructured":"Bayes-Genis\u00a0A, Adler\u00a0Y, de Luna\u00a0AB, Imazio\u00a0M. Colchicine in Pericarditis. Eur Heart\u00a0J. 2017;38(22):1706\u20139.","journal-title":"Eur Heart J"},{"issue":"11","key":"2490_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.5694\/mja14.00846","volume":"201","author":"N Nerlekar","year":"2014","unstructured":"Nerlekar\u00a0N, Beale\u00a0A, Harper\u00a0RW. Colchicine\u2014a short history of an ancient drug. Med J Aust. 2014;201(11):687\u20138.","journal-title":"Med J Aust"},{"issue":"1","key":"2490_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/ard.12.1.16","volume":"12","author":"W Graham","year":"1953","unstructured":"Graham\u00a0W, Roberts\u00a0JB. Intravenous colchicine in the management of gouty arthritis. Ann Rheum Dis. 1953;12(1):16\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2490_CR5","doi-asserted-by":"publisher","DOI":"10.31274\/isudp.1955.89","volume-title":"Colchicine in Agriculture, Medicine, Biology and Chemistry","author":"OJ Eigsti","year":"1955","unstructured":"Eigsti\u00a0OJ, Dustin\u00a0P Jr.. Colchicine in Agriculture, Medicine, Biology and Chemistry. Ames: Iowa State College Press; 1955."},{"issue":"3","key":"2490_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/ard.13.3.190","volume":"13","author":"EF Hartung","year":"1954","unstructured":"Hartung\u00a0EF. History of the use of colchicum and related medicaments in gout; with suggestions for further research. Ann Rheum Dis. 1954;13(3):190\u2013200.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2490_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/archderm.1982.01650190007008","volume":"118","author":"FD Malkinson","year":"1982","unstructured":"Malkinson\u00a0FD. Colchicine. New uses of an old, old drug. Arch Dermatol. 1982;118(7):453\u20137.","journal-title":"Arch Dermatol"},{"issue":"20","key":"2490_CR8","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2013.08.726","volume":"62","author":"S Deftereos","year":"2013","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Papoutsidakis\u00a0N, Panagopoulou\u00a0V, Kossyvakis\u00a0C, Raisakis\u00a0K, et\u00a0al. Colchicine and the heart: pushing the envelope. J\u00a0Am Coll Cardiol. 2013;62(20):1817\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"2490_CR9","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","volume":"42","author":"M Imazio","year":"2021","unstructured":"Imazio\u00a0M, Nidorf\u00a0M. Colchicine and the heart. Eur Heart\u00a0J. 2021;42(28):2745\u201360.","journal-title":"Eur Heart J"},{"issue":"3","key":"2490_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2337\/dc23-1825","volume":"47","author":"F Roubille","year":"2024","unstructured":"Roubille\u00a0F, Bouabdallaoui\u00a0N, Kouz\u00a0S, Waters\u00a0DD, Diaz\u00a0R, Maggioni\u00a0AP, et\u00a0al. Low-Dose Colchicine in Patients With Type\u00a02 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47(3):467\u201370.","journal-title":"Diabetes Care"},{"issue":"10","key":"2490_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","volume":"36","author":"GM Ferron","year":"1996","unstructured":"Ferron\u00a0GM, Rochdi\u00a0M, Jusko\u00a0WJ, Scherrmann\u00a0JM. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J\u00a0Clin Pharmacol. 1996;36(10):874\u201383.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"2490_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/clpt.1993.161","volume":"54","author":"ON Chappey","year":"1993","unstructured":"Chappey\u00a0ON, Niel\u00a0E, Wautier\u00a0JL, Hung\u00a0PP, Dervichian\u00a0M, Cattan\u00a0D, et\u00a0al. Colchicine disposition in human leukocytes after single and multiple oral administration. Clin Pharmacol Ther. 1993;54(4):360\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2490_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1634\/theoncologist.12-8-927","volume":"12","author":"S Marchetti","year":"2007","unstructured":"Marchetti\u00a0S, Mazzanti\u00a0R, Beijnen\u00a0JH, Schellens\u00a0JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P\u2011glycoprotein). Oncologist. 2007;12(8):927\u201341.","journal-title":"Oncologist"},{"issue":"4","key":"2490_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00194404","volume":"46","author":"M Rochdi","year":"1994","unstructured":"Rochdi\u00a0M, Sabouraud\u00a0A, Girre\u00a0C, Venet\u00a0R, Scherrmann\u00a0JM. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol. 1994;46(4):351\u20134.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2490_CR15","first-page":"710","volume":"21","author":"E Ben-Chetrit","year":"1994","unstructured":"Ben-Chetrit\u00a0E, Scherrmann\u00a0JM, Zylber-Katz\u00a0E, Levy\u00a0M. Colchicine disposition in patients with familial Mediterranean fever with renal impairment. J\u00a0Rheumatol. 1994;21(4):710\u20133.","journal-title":"J Rheumatol"},{"key":"2490_CR16","unstructured":"SmPC. Colctab. 2022. https:\/\/aspregister.basg.gv.at\/document\/servlet?action=show&zulnr=141381&type=DOTC_FACH_INFO. Zugegriffen: 11. Nov. 2024."},{"issue":"7","key":"2490_CR17","first-page":"1540","volume":"34","author":"A Tufan","year":"2007","unstructured":"Tufan\u00a0A, Babaoglu\u00a0MO, Akdogan\u00a0A, Yasar\u00a0U, Calguneri\u00a0M, Kalyoncu\u00a0U, et\u00a0al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J\u00a0Rheumatol. 2007;34(7):1540\u20134.","journal-title":"J Rheumatol"},{"key":"2490_CR18","unstructured":"The Rheumatologist. FDA Enforcement Against Injectable Colchicine. 2008. https:\/\/www.the-rheumatologist.org\/article\/fda-enforcement-against-injectable-colchicine. Zugegriffen: 11. Nov. 2024."},{"key":"2490_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.toxrep.2021.07.009","volume":"8","author":"DA Vrachatis","year":"2021","unstructured":"Vrachatis\u00a0DA, Papathanasiou\u00a0KA, Giotaki\u00a0SG, Iliodromitis\u00a0KE, Papaioannou\u00a0TG, Stefanini\u00a0GG, et\u00a0al. Repurposing colchicine\u2019s journey in view of drug-to-drug interactions. A\u00a0review. Toxicol Rep. 2021;8:1389\u201393.","journal-title":"Toxicol Rep"},{"issue":"4","key":"2490_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/rheumatology\/kead625","volume":"63","author":"LK Stamp","year":"2024","unstructured":"Stamp\u00a0LK, Horsley\u00a0C, Te Karu\u00a0L, Dalbeth\u00a0N, Barclay\u00a0M. Colchicine: the good, the bad, the ugly and how to minimize the risks. Rheumatology. 2024;63(4):936\u201344.","journal-title":"Rheumatology"},{"issue":"8","key":"2490_CR21","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","volume":"63","author":"RA Terkeltaub","year":"2011","unstructured":"Terkeltaub\u00a0RA, Furst\u00a0DE, Digiacinto\u00a0JL, Kook\u00a0KA, Davis\u00a0MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63(8):2226\u201337.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2490_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00393-014-1371-6","volume":"73","author":"J Sautner","year":"2014","unstructured":"Sautner\u00a0J. Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations. Z\u00a0Rheumatol. 2014;73(9):836\u201342.","journal-title":"Z Rheumatol"},{"issue":"1","key":"2490_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/toxins16010035","volume":"16","author":"R Huang","year":"2024","unstructured":"Huang\u00a0R, Duan\u00a0J, Huang\u00a0W, Cheng\u00a0Y, Zhu\u00a0B, Li\u00a0F. Inhibition of CYP1A1 Alleviates Colchicine-Induced Hepatotoxicity. Toxins. 2024;16(1):35.","journal-title":"Toxins"},{"issue":"2","key":"2490_CR24","first-page":"ii9","volume":"48","author":"F Perez-Ruiz","year":"2009","unstructured":"Perez-Ruiz\u00a0F. Treating to target: a\u00a0strategy to cure gout. Rheumatology. 2009;48(2):ii9\u2013ii14.","journal-title":"Rheumatology"},{"issue":"7","key":"2490_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth\u00a0N, Phipps-Green\u00a0A, Frampton\u00a0C, Neogi\u00a0T, Taylor\u00a0WJ, Merriman\u00a0TR. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018;77(7):1048\u201352.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2490_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo\u00a0CF, Grainge\u00a0MJ, Zhang\u00a0W, Doherty\u00a0M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"3S","key":"2490_CR27","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","volume":"50","author":"JA Singh","year":"2020","unstructured":"Singh\u00a0JA, Gaffo\u00a0A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11\u2013S6.","journal-title":"Semin Arthritis Rheum"},{"issue":"10287","key":"2490_CR28","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth\u00a0N, Gosling\u00a0AL, Gaffo\u00a0A, Abhishek\u00a0A. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Lancet"},{"issue":"1","key":"2490_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-018-1596-x","volume":"20","author":"P Drivelegka","year":"2018","unstructured":"Drivelegka\u00a0P, Sigurdardottir\u00a0V, Sv\u00e4rd\u00a0A, Jacobsson\u00a0LTH, Dehlin\u00a0M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res Ther. 2018;20(1):108.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2490_CR30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/annrheumdis-2016-210588","volume":"76","author":"MC Fisher","year":"2017","unstructured":"Fisher\u00a0MC, Rai\u00a0SK, Lu\u00a0N, Zhang\u00a0Y, Choi\u00a0HK. The unclosing premature mortality gap in gout: a\u00a0general population-based study. Ann Rheum Dis. 2017;76(7):1289\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2490_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrrheum.2017.27","volume":"13","author":"CF Kuo","year":"2017","unstructured":"Kuo\u00a0CF, Luo\u00a0SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017;13(4):200\u20131.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2490_CR32","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/S2665-9913(23)00338-7","volume":"6","author":"LD Ferguson","year":"2024","unstructured":"Ferguson\u00a0LD, Molenberghs\u00a0G, Verbeke\u00a0G, Rahimi\u00a0K, Rao\u00a0S, McInnes\u00a0IB, et\u00a0al. Gout and incidence of 12 cardiovascular diseases: a\u00a0case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol. 2024;6(3):e156\u2013e67.","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"2490_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00393-016-0147-6","volume":"75","author":"U Kiltz","year":"2016","unstructured":"Kiltz\u00a0U, Alten\u00a0R, Fleck\u00a0M, Kr\u00fcger\u00a0K, Manger\u00a0B, M\u00fcller-Ladner\u00a0U, et\u00a0al. Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh). Z\u00a0Rheumatol. 2016;75(2):11\u201360.","journal-title":"Z Rheumatol"},{"issue":"1","key":"2490_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette\u00a0P, Doherty\u00a0M, Pascual\u00a0E, Barskova\u00a0V, Becce\u00a0F, Casta\u00f1eda-Sanabria\u00a0J, et\u00a0al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2490_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald\u00a0JD, Dalbeth\u00a0N, Mikuls\u00a0T, Brignardello-Petersen\u00a0R, Guyatt\u00a0G, Abeles\u00a0AM, et\u00a0al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744\u201360.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"2490_CR36","first-page":"523","volume":"6","author":"I Hisatome","year":"2023","unstructured":"Hisatome\u00a0I, Hamada\u00a0T, Mizuta\u00a0E, Ohtahara\u00a0A, Kuwabara\u00a0M, Ogino\u00a0K, et\u00a0al. Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition. JMA\u00a0J. 2023;6(4):523\u20136.","journal-title":"JMA J"},{"issue":"7","key":"2490_CR37","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui\u00a0M, Carr\u00a0A, Cameron\u00a0S, Davenport\u00a0G, Doherty\u00a0M, Forrester\u00a0H, et\u00a0al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology. 2017;56(7):1056\u20139.","journal-title":"Rheumatology"},{"issue":"1","key":"2490_CR38","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","volume":"57","author":"A Slobodnick","year":"2018","unstructured":"Slobodnick\u00a0A, Shah\u00a0B, Krasnokutsky\u00a0S, Pillinger\u00a0MH. Update on colchicine, 2017. Rheumatology. 2018;57(1):i4\u2013i11.","journal-title":"Rheumatology"},{"issue":"7081","key":"2490_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon\u00a0F, P\u00e9trilli\u00a0V, Mayor\u00a0A, Tardivel\u00a0A, Tschopp\u00a0J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"2","key":"2490_CR40","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1002\/art.23069","volume":"58","author":"DJ McCarty","year":"2008","unstructured":"McCarty\u00a0DJ. Urate crystals, inflammation, and colchicine. Arthritis Rheum. 2008;58(2):S20\u2013S4.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2490_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.40.6.605","volume":"40","author":"JN Fordham","year":"1981","unstructured":"Fordham\u00a0JN, Kirwan\u00a0J, Cason\u00a0J, Currey\u00a0HL. Prolonged reduction in polymorphonuclear adhesion following oral colchicine. Ann Rheum Dis. 1981;40(6):605\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2490_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","volume":"45","author":"YY Leung","year":"2015","unstructured":"Leung\u00a0YY, Hui\u00a0YLL, Kraus\u00a0VB. Colchicine\u2014Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45(3):341\u201350.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2490_CR43","first-page":"600","volume":"19","author":"E Pascual","year":"1992","unstructured":"Pascual\u00a0E, Castellano\u00a0JA. Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals. J\u00a0Rheumatol. 1992;19(4):600\u20133.","journal-title":"J Rheumatol"},{"issue":"5","key":"2490_CR44","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","volume":"163","author":"C Marques-da-Silva","year":"2011","unstructured":"Marques-da-Silva\u00a0C, Chaves\u00a0MM, Castro\u00a0NG, Coutinho-Silva\u00a0R, Guimaraes\u00a0MZ. Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol. 2011;163(5):912\u201326.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2490_CR45","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub\u00a0RA, Furst\u00a0DE, Bennett\u00a0K, Kook\u00a0KA, Crockett\u00a0RS, Davis\u00a0MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060\u20138.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2490_CR46","first-page":"2429","volume":"31","author":"GC Borstad","year":"2004","unstructured":"Borstad\u00a0GC, Bryant\u00a0LR, Abel\u00a0MP, Scroggie\u00a0DA, Harris\u00a0MD, Alloway\u00a0JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J\u00a0Rheumatol. 2004;31(12):2429\u201332.","journal-title":"J Rheumatol"},{"issue":"23","key":"2490_CR47","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker\u00a0MA, Schumacher\u00a0HR Jr, Wortmann\u00a0RL, MacDonald\u00a0PA, Eustace\u00a0D, Palo\u00a0WA, et\u00a0al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N\u00a0Engl J Med. 2005;353(23):2450\u201361.","journal-title":"N Engl J Med"},{"issue":"11","key":"2490_CR48","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/art.24209","volume":"59","author":"HR Schumacher Jr","year":"2008","unstructured":"Schumacher\u00a0HR Jr, Becker\u00a0MA, Wortmann\u00a0RL, Macdonald\u00a0PA, Hunt\u00a0B, Streit\u00a0J, et\u00a0al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a\u00a028-week, phase\u00a0III, randomized, double-blind, parallel-group trial. Arthritis Rheum. 2008;59(11):1540\u20138.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2490_CR49","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/ar2978","volume":"12","author":"MA Becker","year":"2010","unstructured":"Becker\u00a0MA, Schumacher\u00a0HR, Espinoza\u00a0LR, Wells\u00a0AF, MacDonald\u00a0P, Lloyd\u00a0E, et\u00a0al. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther. 2010;12(2):R63.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2490_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00296-005-0074-3","volume":"26","author":"F Onen","year":"2006","unstructured":"Onen\u00a0F. Familial mediterranean fever. Rheumatol Int. 2006;26(6):489\u201396.","journal-title":"Rheumatol Int"},{"issue":"3","key":"2490_CR51","first-page":"97","volume":"57","author":"A Kucuk","year":"2014","unstructured":"Kucuk\u00a0A, Gezer\u00a0IA, Ucar\u00a0R, Karahan\u00a0AY. Familial Mediterranean Fever. Acta Medica. 2014;57(3):97\u2013104.","journal-title":"Acta Medica"},{"issue":"1","key":"2490_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568010053622984","volume":"4","author":"C Cerquaglia","year":"2005","unstructured":"Cerquaglia\u00a0C, Diaco\u00a0M, Nucera\u00a0G, La Regina\u00a0M, Montalto\u00a0M, Manna\u00a0R. Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy. 2005;4(1):117\u201324.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"1","key":"2490_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/0929867323666151117121706","volume":"23","author":"P Portincasa","year":"2016","unstructured":"Portincasa\u00a0P. Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare. Curr Med Chem. 2016;23(1):60\u201386.","journal-title":"Curr Med Chem"},{"issue":"10","key":"2490_CR54","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","volume":"95","author":"M Centola","year":"2000","unstructured":"Centola\u00a0M, Wood\u00a0G, Frucht\u00a0DM, Galon\u00a0J, Aringer\u00a0M, Farrell\u00a0C, et\u00a0al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95(10):3223\u201331.","journal-title":"Blood"},{"issue":"3","key":"2490_CR55","first-page":"431","volume":"16","author":"E Ben-Chetrit","year":"2003","unstructured":"Ben-Chetrit\u00a0E. Familial Mediterranean fever (FMF) and renal AA amyloidosis\u2014phenotype-genotype correlation, treatment and prognosis. J\u00a0Nephrol. 2003;16(3):431\u20134.","journal-title":"J Nephrol"},{"issue":"4","key":"2490_CR56","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen\u00a0S, Demirkaya\u00a0E, Erer\u00a0B, Livneh\u00a0A, Ben-Chetrit\u00a0E, Giancane\u00a0G, et\u00a0al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"Pt 1","key":"2490_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/bj3230189","volume":"323","author":"A Vandecandelaere","year":"1997","unstructured":"Vandecandelaere\u00a0A, Martin\u00a0SR, Engelborghs\u00a0Y. Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules. Biochem\u00a0J. 1997;323(Pt 1):189\u201396.","journal-title":"Biochem J"},{"issue":"3","key":"2490_CR58","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1084\/jem.171.3.715","volume":"171","author":"AH Ding","year":"1990","unstructured":"Ding\u00a0AH, Porteu\u00a0F, Sanchez\u00a0E, Nathan\u00a0CF. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J\u00a0Exp Med. 1990;171(3):715\u201327.","journal-title":"J Exp Med"},{"issue":"2","key":"2490_CR59","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1172\/JCI118147","volume":"96","author":"BN Cronstein","year":"1995","unstructured":"Cronstein\u00a0BN, Molad\u00a0Y, Reibman\u00a0J, Balakhane\u00a0E, Levin\u00a0RI, Weissmann\u00a0G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J\u00a0Clin Invest. 1995;96(2):994\u20131002.","journal-title":"J Clin Invest"},{"issue":"6","key":"2490_CR60","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jlb.59.6.864","volume":"59","author":"CJ Roberge","year":"1996","unstructured":"Roberge\u00a0CJ, Gaudry\u00a0M, Gilbert\u00a0C, Malawista\u00a0SE, de M\u00e9dicis\u00a0R, Lussier\u00a0A, et\u00a0al. Paradoxical effects of colchicine on the activation of human neutrophilis by chemotactic factors and inflammatory microcrystal. J\u00a0Leukoc Biol. 1996;59(6):864\u201371.","journal-title":"J Leukoc Biol"},{"issue":"6 Pt 1","key":"2490_CR61","first-page":"L1004","volume":"271","author":"M Peters-Golden","year":"1996","unstructured":"Peters-Golden\u00a0M, McNish\u00a0RW, Davis\u00a0JA, Blackwood\u00a0RA, Brock\u00a0TG. Colchicine inhibits arachidonate release and 5\u2011lipoxygenase action in alveolar macrophages. Am J Physiol. 1996;271(6 Pt 1):L1004\u2013L13.","journal-title":"Am J Physiol"},{"issue":"8","key":"2490_CR62","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.1996.tb15353.x","volume":"117","author":"M Pay\u00e1","year":"1996","unstructured":"Pay\u00e1\u00a0M, Terencio\u00a0MC, Ferr\u00e1ndiz\u00a0ML, Alcaraz\u00a0MJ. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br J Pharmacol. 1996;117(8):1773\u20139.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"2490_CR63","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1002\/art.22938","volume":"56","author":"RM Pope","year":"2007","unstructured":"Pope\u00a0RM, Tschopp\u00a0J. The role of interleukin\u20111 and the inflammasome in gout: implications for therapy. Arthritis Rheum. 2007;56(10):3183\u20138.","journal-title":"Arthritis Rheum"},{"key":"2490_CR64","unstructured":"Embryotox. Colchicin. 2024. https:\/\/www.embryotox.de\/arzneimittel\/details\/ansicht\/medikament\/colchicin. Zugegriffen: 11. Nov. 2024."},{"issue":"25","key":"2490_CR65","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJM197212212872514","volume":"287","author":"SE Goldfinger","year":"1972","unstructured":"Goldfinger\u00a0SE. Colchicine for familial Mediterranean fever. N\u00a0Engl J Med. 1972;287(25):1302.","journal-title":"N Engl J Med"},{"issue":"18","key":"2490_CR66","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJM197410312911804","volume":"291","author":"CA Dinarello","year":"1974","unstructured":"Dinarello\u00a0CA, Wolff\u00a0SM, Goldfinger\u00a0SE, Dale\u00a0DC, Alling\u00a0DW. Colchicine therapy for familial mediterranean fever. A\u00a0double-blind trial. N\u00a0Engl J Med. 1974;291(18):934\u20137.","journal-title":"N Engl J Med"},{"issue":"18","key":"2490_CR67","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM197410312911803","volume":"291","author":"D Zemer","year":"1974","unstructured":"Zemer\u00a0D, Revach\u00a0M, Pras\u00a0M, Modan\u00a0B, Schor\u00a0S, Sohar\u00a0E, Gafni\u00a0J. A\u00a0controlled trial of colchicine in preventing attacks of familial mediterranean fever. N\u00a0Engl J Med. 1974;291(18):932\u20134.","journal-title":"N Engl J Med"},{"issue":"4","key":"2490_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","volume":"20","author":"E Ben-Chetrit","year":"1991","unstructured":"Ben-Chetrit\u00a0E, Levy\u00a0M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15\u00a0years. Semin Arthritis Rheum. 1991;20(4):241\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2490_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.31138\/mjr.20230912.stm","volume":"34","author":"ON Shrateh","year":"2023","unstructured":"Shrateh\u00a0ON, Thalji\u00a0M, Jobran\u00a0AWM, Brakat\u00a0AM, Attia\u00a0AM, Abunejma\u00a0FM. Genotype Mutations in Palestinian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine Treatment: A\u00a0Retrospective Cohort Study. Mediterr J Rheumatol. 2023;34(3):332\u201341.","journal-title":"Mediterr J Rheumatol"},{"issue":"42","key":"2490_CR70","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler\u00a0Y, Charron\u00a0PT. 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. Eur Heart\u00a0J. 2015;36(42):2873\u20134.","journal-title":"Eur Heart J"},{"key":"2490_CR71","first-page":"29","volume":"536","author":"RL Gauer","year":"2024","unstructured":"Gauer\u00a0RL, Guess\u00a0JM. Cardiovascular Disease: Inflammatory and Infectious Heart Conditions. FP Essent. 2024;536:29\u201345.","journal-title":"FP Essent"},{"issue":"10","key":"2490_CR72","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.110.986372","volume":"123","author":"M Imazio","year":"2011","unstructured":"Imazio\u00a0M, Brucato\u00a0A, Maestroni\u00a0S, Cumetti\u00a0D, Dominelli\u00a0A, Natale\u00a0G, et\u00a0al. Prevalence of C\u2011reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123(10):1092\u20137.","journal-title":"Circulation"},{"issue":"10","key":"2490_CR73","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/hrt.2009.187138","volume":"96","author":"AL Caforio","year":"2010","unstructured":"Caforio\u00a0AL, Brucato\u00a0A, Doria\u00a0A, Brambilla\u00a0G, Angelini\u00a0A, Ghirardello\u00a0A, et\u00a0al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96(10):779\u201384.","journal-title":"Heart"},{"issue":"E","key":"2490_CR74","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1093\/eurheartj\/suab097","volume":"23","author":"R Del Pinto","year":"2021","unstructured":"Del Pinto\u00a0R, Ferri\u00a0C. Recurrent pericarditis is less scary: the new therapeutic solutions. Eur Heart J Suppl. 2021;23(E):E83\u2013E6.","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"2490_CR75","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1002\/jcp.27436","volume":"234","author":"A Bonaventura","year":"2019","unstructured":"Bonaventura\u00a0A, Montecucco\u00a0F. Inflammation and pericarditis: Are neutrophils actors behind the scenes? J\u00a0Cell Physiol. 2019;234(5):5390\u20138.","journal-title":"J Cell Physiol"},{"issue":"18","key":"2490_CR76","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato\u00a0A, Imazio\u00a0M, Gattorno\u00a0M, Lazaros\u00a0G, Maestroni\u00a0S, Carraro\u00a0M, et\u00a0al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA. 2016;316(18):1906\u201312.","journal-title":"JAMA"},{"issue":"11","key":"2490_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11886-021-01589-x","volume":"23","author":"A Vecchi\u00e9","year":"2021","unstructured":"Vecchi\u00e9\u00a0A, Del Buono\u00a0MG, Chiabrando\u00a0GJ, Dentali\u00a0F, Abbate\u00a0A, Bonaventura\u00a0A. Interleukin\u20111 and the NLRP3 Inflammasome in Pericardial Disease. Curr Cardiol Rep. 2021;23(11):157.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"2490_CR78","doi-asserted-by":"publisher","first-page":"249","DOI":"10.23736\/S0031-0808.20.04205-6","volume":"63","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura\u00a0A, Vecchi\u00e9\u00a0A, Mauro\u00a0AG, Brucato\u00a0AL, Imazio\u00a0M, Abbate\u00a0A. An update on the pathophysiology of acute and recurrent pericarditis. Panminerva Med. 2021;63(3):249\u201360.","journal-title":"Panminerva Med"},{"issue":"2","key":"2490_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacbts.2020.11.016","volume":"6","author":"AG Mauro","year":"2021","unstructured":"Mauro\u00a0AG, Bonaventura\u00a0A, Vecchi\u00e9\u00a0A, Mezzaroma\u00a0E, Carbone\u00a0S, Narayan\u00a0P, et\u00a0al. The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches. JACC Basic Transl Sci. 2021;6(2):137\u201350.","journal-title":"JACC Basic Transl Sci"},{"issue":"13","key":"2490_CR80","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","volume":"112","author":"M Imazio","year":"2005","unstructured":"Imazio\u00a0M, Bobbio\u00a0M, Cecchi\u00a0E, Demarie\u00a0D, Demichelis\u00a0B, Pomari\u00a0F, et\u00a0al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012\u20136.","journal-title":"Circulation"},{"issue":"16","key":"2490_CR81","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","volume":"369","author":"M Imazio","year":"2013","unstructured":"Imazio\u00a0M, Brucato\u00a0A, Cemin\u00a0R, Ferrua\u00a0S, Maggiolini\u00a0S, Beqaraj\u00a0F, et\u00a0al. A\u00a0randomized trial of colchicine for acute pericarditis. N\u00a0Engl J Med. 2013;369(16):1522\u20138.","journal-title":"N Engl J Med"},{"issue":"9","key":"2490_CR82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.recesp.2018.11.021","volume":"72","author":"A Sambola","year":"2019","unstructured":"Sambola\u00a0A, Roca Luque\u00a0I, Merc\u00e9\u00a0J, Alguersuari\u00a0J, Francisco-Pascual\u00a0J, Garc\u00eda-Dorado\u00a0D, et\u00a0al. Colchicine Administered in the First Episode of Acute Idiopathic Pericarditis: A\u00a0Randomized Multicenter Open-label Study. Rev Esp Cardiol. 2019;72(9):709\u201316.","journal-title":"Rev Esp Cardiol"},{"issue":"17","key":"2490_CR83","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","volume":"165","author":"M Imazio","year":"2005","unstructured":"Imazio\u00a0M, Bobbio\u00a0M, Cecchi\u00a0E, Demarie\u00a0D, Pomari\u00a0F, Moratti\u00a0M, et\u00a0al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165(17):1987\u201391.","journal-title":"Arch Intern Med"},{"issue":"7","key":"2490_CR84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","volume":"155","author":"M Imazio","year":"2011","unstructured":"Imazio\u00a0M, Brucato\u00a0A, Cemin\u00a0R, Ferrua\u00a0S, Belli\u00a0R, Maestroni\u00a0S, et\u00a0al. Colchicine for recurrent pericarditis (CORP): a\u00a0randomized trial. Ann Intern Med. 2011;155(7):409\u201314.","journal-title":"Ann Intern Med"},{"issue":"9936","key":"2490_CR85","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","volume":"383","author":"M Imazio","year":"2014","unstructured":"Imazio\u00a0M, Belli\u00a0R, Brucato\u00a0A, Cemin\u00a0R, Ferrua\u00a0S, Beqaraj\u00a0F, et\u00a0al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a\u00a0multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383(9936):2232\u20137.","journal-title":"Lancet"},{"issue":"8","key":"2490_CR86","first-page":"CD010652","volume":"2014","author":"S Alabed","year":"2014","unstructured":"Alabed\u00a0S, Cabello\u00a0JB, Irving\u00a0GJ, Qintar\u00a0M, Burls\u00a0A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;2014(8):CD10652.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2490_CR87","doi-asserted-by":"publisher","first-page":"e002599","DOI":"10.1136\/openhrt-2023-002599","volume":"11","author":"V Collini","year":"2024","unstructured":"Collini\u00a0V, Andreis\u00a0A, De Biasio\u00a0M, De Martino\u00a0M, Isola\u00a0M, Croatto\u00a0N, et\u00a0al. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis. Open Heart. 2024;11(1):e2599.","journal-title":"Open Heart"},{"issue":"11","key":"2490_CR88","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.amjcard.2009.01.366","volume":"103","author":"M Imazio","year":"2009","unstructured":"Imazio\u00a0M, Negro\u00a0A, Belli\u00a0R, Beqaraj\u00a0F, Forno\u00a0D, Giammaria\u00a0M, et\u00a0al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009;103(11):1525\u20139.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2490_CR89","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara\u00a0PT, Kushner\u00a0FG, Ascheim\u00a0DD, Casey\u00a0DE Jr, Chung\u00a0MK, de Lemos\u00a0JA, et\u00a0al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a\u00a0report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362\u2013e425.","journal-title":"Circulation"},{"issue":"1","key":"2490_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2007.10.053","volume":"127","author":"M Imazio","year":"2008","unstructured":"Imazio\u00a0M, Trinchero\u00a0R. Myopericarditis: Etiology, management, and prognosis. Int J Cardiol. 2008;127(1):17\u201326.","journal-title":"Int J Cardiol"},{"issue":"2","key":"2490_CR91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1586\/erc.12.184","volume":"11","author":"M Imazio","year":"2013","unstructured":"Imazio\u00a0M, Cooper\u00a0LT. Management of myopericarditis. Expert Rev Cardiovasc Ther. 2013;11(2):193\u2013201.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"33","key":"2490_CR92","doi-asserted-by":"publisher","first-page":"2636-48","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio\u00a0AL, Pankuweit\u00a0S, Arbustini\u00a0E, Basso\u00a0C, Gimeno-Blanes\u00a0J, Felix\u00a0SB, et\u00a0al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a\u00a0position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J. 2013;34(33):2636-48\u20132648a\u20132648d.","journal-title":"Eur Heart J"},{"issue":"1","key":"2490_CR93","first-page":"116","volume":"116","author":"R Khatib","year":"1990","unstructured":"Khatib\u00a0R, Reyes\u00a0MP, Smith\u00a0F, Khatib\u00a0G, Rezkalla\u00a0S. Enhancement of coxsackievirus B4 virulence by indomethacin. J\u00a0Lab Clin Med. 1990;116(1):116\u201320.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"2490_CR94","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ehf2.13845","volume":"9","author":"K Pappritz","year":"2022","unstructured":"Pappritz\u00a0K, Lin\u00a0J, El-Shafeey\u00a0M, Fechner\u00a0H, K\u00fchl\u00a0U, Alogna\u00a0A, et\u00a0al. Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis. ESC Heart Fail. 2022;9(2):925\u201341.","journal-title":"ESC Heart Fail"},{"issue":"10","key":"2490_CR95","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/heartjnl-2023-323484","volume":"110","author":"V Collini","year":"2024","unstructured":"Collini\u00a0V, De Martino\u00a0M, Andreis\u00a0A, De Biasio\u00a0M, Gaspard\u00a0F, Paneva\u00a0E, et\u00a0al. Efficacy and safety of colchicine for the treatment of myopericarditis. Heart. 2024;110(10):735\u20139.","journal-title":"Heart"},{"issue":"3","key":"2490_CR96","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti\u00a0J, Wijns\u00a0W, Saraste\u00a0A, Capodanno\u00a0D, Barbato\u00a0E, Funck-Brentano\u00a0C, et\u00a0al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart\u00a0J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"7407","key":"2490_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta\u00a0P, Courties\u00a0G, Wei\u00a0Y, Leuschner\u00a0F, Gorbatov\u00a0R, Robbins\u00a0CS, et\u00a0al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325\u20139.","journal-title":"Nature"},{"issue":"1","key":"2490_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2459\/JCM.0000000000001079","volume":"22","author":"A Andreis","year":"2021","unstructured":"Andreis\u00a0A, Imazio\u00a0M, De Ferrari\u00a0GM. Colchicine for the treatment of cardiovascular diseases: old drug, new targets. J\u00a0Cardiovasc Med. 2021;22(1):1\u20138.","journal-title":"J Cardiovasc Med"},{"issue":"1","key":"2490_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca\u00a0R, Heslinga\u00a0SC, Rollefstad\u00a0S, Heslinga\u00a0M, McInnes\u00a0IB, Peters\u00a0MJ, et\u00a0al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"2490_CR100","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet\u00a0JP, Thiele\u00a0H, Barbato\u00a0E, Barth\u00e9l\u00e9my\u00a0O, Bauersachs\u00a0J, Bhatt\u00a0DL, et\u00a0al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart\u00a0J. 2021;42(14):1289\u2013367.","journal-title":"Eur Heart J"},{"issue":"2","key":"2490_CR101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez\u00a0B, James\u00a0S, Agewall\u00a0S, Antunes\u00a0MJ, Bucciarelli-Ducci\u00a0C, Bueno\u00a0H, et\u00a0al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart\u00a0J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"20","key":"2490_CR102","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/heartjnl-2020-317108","volume":"106","author":"M Imazio","year":"2020","unstructured":"Imazio\u00a0M, Andreis\u00a0A, Brucato\u00a0A, Adler\u00a0Y, De Ferrari\u00a0GM. Colchicine for acute and chronic coronary syndromes. Heart. 2020;106(20):1555\u201360.","journal-title":"Heart"},{"issue":"23","key":"2490_CR103","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","volume":"106","author":"T Naruko","year":"2002","unstructured":"Naruko\u00a0T, Ueda\u00a0M, Haze\u00a0K, van der Wal\u00a0AC, van der Loos\u00a0CM, Itoh\u00a0A, et\u00a0al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106(23):2894\u2013900.","journal-title":"Circulation"},{"issue":"3","key":"2490_CR104","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14017430601164263","volume":"41","author":"J Shu","year":"2007","unstructured":"Shu\u00a0J, Ren\u00a0N, Du\u00a0JB, Zhang\u00a0M, Cong\u00a0HL, Huang\u00a0TG. Increased levels of interleukin\u20116 and matrix metalloproteinase\u20119 are of cardiac origin in acute coronary syndrome. Scand Cardiovasc\u00a0J. 2007;41(3):149\u201354.","journal-title":"Scand Cardiovasc J"},{"issue":"4","key":"2490_CR105","doi-asserted-by":"publisher","first-page":"e0231582","DOI":"10.1371\/journal.pone.0231582","volume":"15","author":"M Higazi","year":"2020","unstructured":"Higazi\u00a0M, Abdeen\u00a0S, Abu-Fanne\u00a0R, Heyman\u00a0SN, Masarwy\u00a0A, Bdeir\u00a0K, et\u00a0al. Opposing effects of HNP1 (\u03b1-defensin-1) on plasma cholesterol and atherogenesis. PLoS ONE. 2020;15(4):e231582.","journal-title":"PLoS ONE"},{"issue":"5","key":"2490_CR106","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood-2018-07-861237","volume":"133","author":"R Abu-Fanne","year":"2019","unstructured":"Abu-Fanne\u00a0R, Stepanova\u00a0V, Litvinov\u00a0RI, Abdeen\u00a0S, Bdeir\u00a0K, Higazi\u00a0M, et\u00a0al. Neutrophil \u03b1\u2011defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability. Blood. 2019;133(5):481\u201393.","journal-title":"Blood"},{"issue":"2","key":"2490_CR107","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross\u00a0R. Atherosclerosis\u2014an inflammatory disease. N\u00a0Engl J Med. 1999;340(2):115\u201326.","journal-title":"N Engl J Med"},{"issue":"4","key":"2490_CR108","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(01)01485-1","volume":"38","author":"MI Furman","year":"2001","unstructured":"Furman\u00a0MI, Barnard\u00a0MR, Krueger\u00a0LA, Fox\u00a0ML, Shilale\u00a0EA, Lessard\u00a0DM, et\u00a0al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J\u00a0Am Coll Cardiol. 2001;38(4):1002\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"7255","key":"2490_CR109","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","volume":"321","author":"J Danesh","year":"2000","unstructured":"Danesh\u00a0J, Whincup\u00a0P, Walker\u00a0M, Lennon\u00a0L, Thomson\u00a0A, Appleby\u00a0P, et\u00a0al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321(7255):199\u2013204.","journal-title":"BMJ"},{"issue":"1","key":"2490_CR110","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker\u00a0PM, Cannon\u00a0CP, Morrow\u00a0D, Rifai\u00a0N, Rose\u00a0LM, McCabe\u00a0CH, et\u00a0al. C\u2011reactive protein levels and outcomes after statin therapy. N\u00a0Engl J Med. 2005;352(1):20\u20138.","journal-title":"N Engl J Med"},{"issue":"9670","key":"2490_CR111","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","volume":"373","author":"PM Ridker","year":"2009","unstructured":"Ridker\u00a0PM, Danielson\u00a0E, Fonseca\u00a0FA, Genest\u00a0J, Gotto\u00a0AM Jr, Kastelein\u00a0JJ, et\u00a0al. Reduction in C\u2011reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a\u00a0prospective study of the JUPITER trial. Lancet. 2009;373(9670):1175\u201382.","journal-title":"Lancet"},{"issue":"1","key":"2490_CR112","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12471-021-01605-3","volume":"30","author":"ATL Fiolet","year":"2022","unstructured":"Fiolet\u00a0ATL, Opstal\u00a0TSJ, Silvis\u00a0MJM, Cornel\u00a0JH, Mosterd\u00a0A. Targeting residual inflammatory risk in coronary disease: to catch a\u00a0monkey by its tail. Neth Heart\u00a0J. 2022;30(1):25\u201337.","journal-title":"Neth Heart J"},{"key":"2490_CR113","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","volume":"269","author":"GJ Mart\u00ednez","year":"2018","unstructured":"Mart\u00ednez\u00a0GJ, Celermajer\u00a0DS, Patel\u00a0S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262\u201371.","journal-title":"Atherosclerosis"},{"issue":"2","key":"2490_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","volume":"31","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz\u00a0F, Becker\u00a0MA. Inflammation: a\u00a0possible mechanism for a\u00a0causative role of hyperuricemia\/gout in cardiovascular disease. Curr Med Res Opin. 2015;31(2):9\u201314.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2490_CR115","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/biomedicines12030701","volume":"12","author":"A Mitsis","year":"2024","unstructured":"Mitsis\u00a0A, Kyriakou\u00a0M, Sokratous\u00a0S, Karmioti\u00a0G, Drakomathioulakis\u00a0M, Myrianthefs\u00a0M, et\u00a0al. Exploring the Landscape of Anti-Inflammatory Trials: A\u00a0Comprehensive Review of Strategies for Targeting Inflammation in Acute Myocardial Infraction. Biomedicines. 2024;12(3):701.","journal-title":"Biomedicines"},{"issue":"12","key":"2490_CR116","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker\u00a0PM, Everett\u00a0BM, Thuren\u00a0T, MacFadyen\u00a0JG, Chang\u00a0WH, Ballantyne\u00a0C, et\u00a0al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N\u00a0Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"2490_CR117","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12950-023-00366-7","volume":"20","author":"H Zhou","year":"2023","unstructured":"Zhou\u00a0H, Khan\u00a0D, Hussain\u00a0SM, Gerdes\u00a0N, Hagenbeck\u00a0C, Rana\u00a0M, et\u00a0al. Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-\u03baB and MAPKs: implications in vascular diseases. J\u00a0Inflamm. 2023;20(1):41.","journal-title":"J Inflamm"},{"key":"2490_CR118","doi-asserted-by":"publisher","first-page":"898690","DOI":"10.3389\/fimmu.2022.898690","volume":"13","author":"U Meyer-Lindemann","year":"2022","unstructured":"Meyer-Lindemann\u00a0U, Mauersberger\u00a0C, Schmidt\u00a0AC, Moggio\u00a0A, Hinterdobler\u00a0J, Li\u00a0X, et\u00a0al. Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation. Front Immunol. 2022;13:898690.","journal-title":"Front Immunol"},{"issue":"8","key":"2490_CR119","doi-asserted-by":"publisher","first-page":"e0237665","DOI":"10.1371\/journal.pone.0237665","volume":"15","author":"ATL Fiolet","year":"2020","unstructured":"Fiolet\u00a0ATL, Silvis\u00a0MJM, Opstal\u00a0TSJ, Bax\u00a0WA, van der Horst\u00a0FAL, Mosterd\u00a0A, et\u00a0al. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C\u2011reactive protein. PLoS ONE. 2020;15(8):e237665.","journal-title":"PLoS ONE"},{"issue":"2 Pt 2","key":"2490_CR120","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","volume":"11","author":"K Vaidya","year":"2018","unstructured":"Vaidya\u00a0K, Arnott\u00a0C, Mart\u00ednez\u00a0GJ, Ng\u00a0B, McCormack\u00a0S, Sullivan\u00a0DR, et\u00a0al. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A\u00a0CT Coronary Angiography Study. JACC Cardiovasc Imaging. 2018;11(2 Pt 2):305\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2490_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.01.004","volume":"125","author":"M Madanchi","year":"2024","unstructured":"Madanchi\u00a0M, Young\u00a0M, Tersalvi\u00a0G, Cioffi\u00a0MG, Attinger-Toller\u00a0A, Cuculi\u00a0F, et\u00a0al. The impact of colchicine on patients with acute and chronic coronary artery disease. Eur J Intern Med. 2024;125:1\u20139.","journal-title":"Eur J Intern Med"},{"key":"2490_CR122","unstructured":"SmPC. Lodoco. 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215727s000lbl.pdf. Zugegriffen: 11. Nov. 2024."},{"issue":"36","key":"2490_CR123","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints\u00a0C, Andreotti\u00a0F, Koskinas\u00a0KC, Rossello\u00a0X, Adamo\u00a0M, Ainslie\u00a0J, et\u00a0al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart\u00a0J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"8","key":"2490_CR124","first-page":"665","volume":"24","author":"SA Di Fusco","year":"2023","unstructured":"Di Fusco\u00a0SA, Imazio\u00a0M, Rizzello\u00a0V, Gatto\u00a0L, Spinelli\u00a0A, Aquilani\u00a0S, et\u00a0al. ANMCO Position paper: Colchicine as a\u00a0therapeutic agent in coronary syndromes. G\u00a0Ital Cardiol. 2023;24(8):665\u201374.","journal-title":"G Ital Cardiol"},{"issue":"1","key":"2490_CR125","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","volume":"135","author":"PC Robinson","year":"2022","unstructured":"Robinson\u00a0PC, Terkeltaub\u00a0R, Pillinger\u00a0MH, Shah\u00a0B, Karalis\u00a0V, Karatza\u00a0E, et\u00a0al. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. Am J Med. 2022;135(1):32\u20138.","journal-title":"Am J Med"},{"issue":"16","key":"2490_CR126","doi-asserted-by":"publisher","first-page":"e021198","DOI":"10.1161\/JAHA.121.021198","volume":"10","author":"T Kofler","year":"2021","unstructured":"Kofler\u00a0T, Kurmann\u00a0R, Lehnick\u00a0D, Cioffi\u00a0GM, Chandran\u00a0S, Attinger-Toller\u00a0A, et\u00a0al. Colchicine in Patients With Coronary Artery Disease: A\u00a0Systematic Review and Meta-Analysis of Randomized Trials. J\u00a0Am Heart Assoc. 2021;10(16):e21198.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2490_CR127","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.cjca.2021.08.009","volume":"37","author":"G Marquis-Gravel","year":"2021","unstructured":"Marquis-Gravel\u00a0G, Goodman\u00a0SG, Anderson\u00a0TJ, Bell\u00a0AD, Bewick\u00a0D, Cox\u00a0J, et\u00a0al. Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians. Can J Cardiol. 2021;37(11):1837\u201345.","journal-title":"Can J Cardiol"},{"issue":"8","key":"2490_CR128","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1253\/circrep.CR-21-0065","volume":"3","author":"AM Abrantes","year":"2021","unstructured":"Abrantes\u00a0AM, Nogueira-Garcia\u00a0B, Alves\u00a0M, Teixeira Passos\u00a0D, Brito\u00a0D, Pinto\u00a0FJ, et\u00a0al. Low-Dose Colchicine in Coronary Artery Disease\u2014Systematic Review and Meta-Analysis. Circ Rep. 2021;3(8):457\u201364.","journal-title":"Circ Rep"},{"issue":"4","key":"2490_CR129","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/bcp.15041","volume":"88","author":"I Byty\u00e7i","year":"2022","unstructured":"Byty\u00e7i\u00a0I, Bajraktari\u00a0G, Penson\u00a0PE, Henein\u00a0MY, Banach\u00a0M. Efficacy and safety of colchicine in patients with coronary artery disease: A\u00a0systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2022;88(4):1520\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"17","key":"2490_CR130","doi-asserted-by":"publisher","first-page":"8087","DOI":"10.1111\/jcmm.16798","volume":"25","author":"Y Li","year":"2021","unstructured":"Li\u00a0Y, Zhang\u00a0Y, Lu\u00a0J, Yin\u00a0Y, Xie\u00a0J, Xu\u00a0B. Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy. J\u00a0Cell Mol Med. 2021;25(17):8087\u201394.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2490_CR131","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/MJT.0000000000001409","volume":"30","author":"S Sethuramalingam","year":"2023","unstructured":"Sethuramalingam\u00a0S, Maiti\u00a0R, Hota\u00a0D, Srinivasan\u00a0A. Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A\u00a0Meta-analysis of Clinical Trials. Am J Ther. 2023;30(3):e197\u2013e208.","journal-title":"Am J Ther"},{"issue":"10","key":"2490_CR132","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00392-021-01828-9","volume":"110","author":"D D\u2019Amario","year":"2021","unstructured":"D\u2019Amario\u00a0D, Cappetta\u00a0D, Cappannoli\u00a0L, Princi\u00a0G, Migliaro\u00a0S, Diana\u00a0G, et\u00a0al. Colchicine in ischemic heart disease: the good, the bad and the ugly. Clin Res Cardiol. 2021;110(10):1531\u201342.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"2490_CR133","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.hroo.2024.01.001","volume":"5","author":"C de Asmundis","year":"2024","unstructured":"de Asmundis\u00a0C, Marcon\u00a0L, Pannone\u00a0L, Rocca\u00a0DDG, Lakkireddy\u00a0D, Beaver\u00a0TM, et\u00a0al. Pericarditis prophylactic therapy after sinus node-sparing hybrid ablation for inappropriate sinus tachycardia\/postural orthostatic sinus tachycardia. Heart Rhythm O2. 2024;5(2):137\u201344.","journal-title":"Heart Rhythm O2"},{"issue":"19","key":"2490_CR134","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf\u00a0SM, Fiolet\u00a0ATL, Mosterd\u00a0A, Eikelboom\u00a0JW, Schut\u00a0A, Opstal\u00a0TSJ, et\u00a0al. Colchicine in Patients with Chronic Coronary Disease. N\u00a0Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"6","key":"2490_CR135","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","volume":"99","author":"M Nidorf","year":"2007","unstructured":"Nidorf\u00a0M, Thompson\u00a0PL. Effect of colchicine (0.5\u202fmg twice daily) on high-sensitivity C\u2011reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. Am J Cardiol. 2007;99(6):805\u20137.","journal-title":"Am J Cardiol"},{"issue":"7","key":"2490_CR136","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.111533","volume":"39","author":"DB Crittenden","year":"2012","unstructured":"Crittenden\u00a0DB, Lehmann\u00a0RA, Schneck\u00a0L, Keenan\u00a0RT, Shah\u00a0B, Greenberg\u00a0JD, et\u00a0al. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. J\u00a0Rheumatol. 2012;39(7):1458\u201364.","journal-title":"J Rheumatol"},{"issue":"4","key":"2490_CR137","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf\u00a0SM, Eikelboom\u00a0JW, Budgeon\u00a0CA, Thompson\u00a0PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J\u00a0Am Coll Cardiol. 2013;61(4):404\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2490_CR138","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","volume":"33","author":"NC Raju","year":"2012","unstructured":"Raju\u00a0NC, Yi\u00a0Q, Nidorf\u00a0M, Fagel\u00a0ND, Hiralal\u00a0R, Eikelboom\u00a0JW. Effect of colchicine compared with placebo on high sensitivity C\u2011reactive protein in patients with acute coronary syndrome or acute stroke: a\u00a0pilot randomized controlled trial. J\u00a0Thromb Thrombolysis. 2012;33(1):88\u201394.","journal-title":"J Thromb Thrombolysis"},{"issue":"15","key":"2490_CR139","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","volume":"132","author":"S Deftereos","year":"2015","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Angelidis\u00a0C, Alexopoulos\u00a0N, Filippatos\u00a0G, Papoutsidakis\u00a0N, et\u00a0al. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A\u00a0Pilot Study. Circulation. 2015;132(15):1395\u2013403.","journal-title":"Circulation"},{"issue":"26","key":"2490_CR140","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif\u00a0JC, Kouz\u00a0S, Waters\u00a0DD, Bertrand\u00a0OF, Diaz\u00a0R, Maggioni\u00a0AP, et\u00a0al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N\u00a0Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"42","key":"2490_CR141","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","volume":"41","author":"N Bouabdallaoui","year":"2020","unstructured":"Bouabdallaoui\u00a0N, Tardif\u00a0JC, Waters\u00a0DD, Pinto\u00a0FJ, Maggioni\u00a0AP, Diaz\u00a0R, et\u00a0al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart\u00a0J. 2020;41(42):4092\u20139.","journal-title":"Eur Heart J"},{"issue":"4","key":"2490_CR142","doi-asserted-by":"publisher","first-page":"e008717","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","volume":"13","author":"B Shah","year":"2020","unstructured":"Shah\u00a0B, Pillinger\u00a0M, Zhong\u00a0H, Cronstein\u00a0B, Xia\u00a0Y, Lorin\u00a0JD, et\u00a0al. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial. Circ Cardiovasc Interv. 2020;13(4):e8717.","journal-title":"Circ Cardiovasc Interv"},{"issue":"20","key":"2490_CR143","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"DC Tong","year":"2020","unstructured":"Tong\u00a0DC, Quinn\u00a0S, Nasis\u00a0A, Hiew\u00a0C, Roberts-Thomson\u00a0P, Adams\u00a0H, et\u00a0al. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial. Circulation. 2020;142(20):1890\u2013900.","journal-title":"Circulation"},{"issue":"19","key":"2490_CR144","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/CIRCULATIONAHA.121.054610","volume":"144","author":"DC Tong","year":"2021","unstructured":"Tong\u00a0DC, Bloom\u00a0JE, Quinn\u00a0S, Nasis\u00a0A, Hiew\u00a0C, Roberts-Thomson\u00a0P, et\u00a0al. Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial. Circulation. 2021;144(19):1584\u20136.","journal-title":"Circulation"},{"issue":"1","key":"2490_CR145","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40119-022-00298-y","volume":"12","author":"J Nogic","year":"2023","unstructured":"Nogic\u00a0J, Mehta\u00a0O, Tong\u00a0D, Brown\u00a0AJ, Layland\u00a0J. Colchicine in the Management of Acute Coronary Syndrome: A\u00a0Meta-analysis. Cardiol Ther. 2023;12(1):171\u201381.","journal-title":"Cardiol Ther"},{"issue":"1","key":"2490_CR146","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12872-021-02393-9","volume":"21","author":"M Akrami","year":"2021","unstructured":"Akrami\u00a0M, Izadpanah\u00a0P, Bazrafshan\u00a0M, Hatamipour\u00a0U, Nouraein\u00a0N, Drissi\u00a0HB, et\u00a0al. Effects of colchicine on major adverse cardiac events in next 6\u2011month period after acute coronary syndrome occurrence; a\u00a0randomized placebo-control trial. BMC Cardiovasc Disord. 2021;21(1):583.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"2490_CR147","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/eurheartj\/ehae042","volume":"45","author":"F Huet","year":"2024","unstructured":"Huet\u00a0F, Mariano-Goulart\u00a0D, Aguilhon\u00a0S, Delbaere\u00a0Q, Lacampagne\u00a0A, Fauconnier\u00a0J, et\u00a0al. Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial. Eur Heart\u00a0J. 2024;45(9):725\u20137.","journal-title":"Eur Heart J"},{"issue":"15","key":"2490_CR148","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jcin.2023.05.035","volume":"16","author":"SY Lee","year":"2023","unstructured":"Lee\u00a0SY, Jeong\u00a0YH, Yun\u00a0KH, Cho\u00a0JY, Gorog\u00a0DA, Angiolillo\u00a0DJ, et\u00a0al. P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study. JACC Cardiovasc Interv. 2023;16(15):1845\u201355.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2490_CR149","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/FJC.0000000000001509","volume":"83","author":"M Yu","year":"2024","unstructured":"Yu\u00a0M, Zhu\u00a0ZF, Yang\u00a0F, Yuan\u00a0YF, Liao\u00a0SD, Liu\u00a0ML, et\u00a0al. Different Anti-inflammatory Drugs on High-Sensitivity C\u2011Reactive Protein in Patients After Percutaneous Coronary Intervention: A\u00a0Pilot Randomized Clinical Trial. J\u00a0Cardiovasc Pharmacol. 2024;83(3):234\u201342.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"2490_CR150","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","volume":"144","author":"N Mewton","year":"2021","unstructured":"Mewton\u00a0N, Roubille\u00a0F, Bresson\u00a0D, Prieur\u00a0C, Bouleti\u00a0C, Bochaton\u00a0T, et\u00a0al. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. 2021;144(11):859\u201369.","journal-title":"Circulation"},{"issue":"1","key":"2490_CR151","doi-asserted-by":"publisher","first-page":"e002474","DOI":"10.1136\/openhrt-2023-002474","volume":"11","author":"C Bouleti","year":"2024","unstructured":"Bouleti\u00a0C, Viscogliosi\u00a0S, Bresson\u00a0D, Leboube\u00a0S, Bochaton\u00a0T, El-Jonhy\u00a0N, et\u00a0al. Colchicine in acute myocardial infarction: cardiovascular events at 1\u2011year follow up. Open Heart. 2024;11(1):e2474.","journal-title":"Open Heart"},{"issue":"5","key":"2490_CR152","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C, et\u00a0al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"21","key":"2490_CR153","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1001\/jama.2020.23700","volume":"325","author":"JR Baman","year":"2021","unstructured":"Baman\u00a0JR, Passman\u00a0RS. Atrial Fibrillation. JAMA. 2021;325(21):2218.","journal-title":"JAMA"},{"issue":"24","key":"2490_CR154","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles\u00a0RJ, Martin\u00a0DO, Apperson-Hansen\u00a0C, Houghtaling\u00a0PL, Rautaharju\u00a0P, Kronmal\u00a0RA, et\u00a0al. Inflammation as a\u00a0risk factor for atrial fibrillation. Circulation. 2003;108(24):3006\u201310.","journal-title":"Circulation"},{"issue":"9","key":"2490_CR155","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.amjcard.2009.01.010","volume":"103","author":"T Koyama","year":"2009","unstructured":"Koyama\u00a0T, Sekiguchi\u00a0Y, Tada\u00a0H, Arimoto\u00a0T, Yamasaki\u00a0H, Kuroki\u00a0K, et\u00a0al. Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation. Am J Cardiol. 2009;103(9):1249\u201354.","journal-title":"Am J Cardiol"},{"issue":"24","key":"2490_CR156","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung\u00a0MK, Martin\u00a0DO, Sprecher\u00a0D, Wazni\u00a0O, Kanderian\u00a0A, Carnes\u00a0CA, et\u00a0al. C\u2011reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104(24):2886\u201391.","journal-title":"Circulation"},{"issue":"10","key":"2490_CR157","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","volume":"96","author":"P Bruins","year":"1997","unstructured":"Bruins\u00a0P, te Velthuis\u00a0H, Yazdanbakhsh\u00a0AP, Jansen\u00a0PG, van Hardevelt\u00a0FW, de Beaumont\u00a0EM, et\u00a0al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C\u2011reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(10):3542\u20138.","journal-title":"Circulation"},{"issue":"5","key":"2490_CR158","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.athoracsur.2004.10.004","volume":"79","author":"B Lo","year":"2005","unstructured":"Lo\u00a0B, Fijnheer\u00a0R, Nierich\u00a0AP, Bruins\u00a0P, Kalkman\u00a0CJ. C\u2011reactive protein is a\u00a0risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg. 2005;79(5):1530\u20135.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2490_CR159","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/FJC.0000000000000313","volume":"66","author":"A Gutierrez","year":"2015","unstructured":"Gutierrez\u00a0A, Van Wagoner\u00a0DR. Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update. J\u00a0Cardiovasc Pharmacol. 2015;66(6):523\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"20","key":"2490_CR160","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","volume":"138","author":"C Yao","year":"2018","unstructured":"Yao\u00a0C, Veleva\u00a0T, Scott\u00a0L Jr, Cao\u00a0S, Li\u00a0L, Chen\u00a0G, et\u00a0al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation. 2018;138(20):2227\u201342.","journal-title":"Circulation"},{"issue":"1","key":"2490_CR161","first-page":"61","volume":"145","author":"SG Deftereos","year":"2022","unstructured":"Deftereos\u00a0SG, Beerkens\u00a0FJ, Shah\u00a0B, Giannopoulos\u00a0G, Vrachatis\u00a0DA, Giotaki\u00a0SG, et\u00a0al. Colchicine in Cardiovascular Disease: In-Depth Review. Circulation. 2022;145(1):61\u201378.","journal-title":"Circulation"},{"issue":"1","key":"2490_CR162","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/europace\/euy110","volume":"21","author":"G Boriani","year":"2019","unstructured":"Boriani\u00a0G, Fauchier\u00a0L, Aguinaga\u00a0L, Beattie\u00a0JM, Blomstrom Lundqvist\u00a0C, Cohen\u00a0A, et\u00a0al. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace. 2019;21(1):7\u20138.","journal-title":"Europace"},{"issue":"8","key":"2490_CR163","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","volume":"51","author":"N Echahidi","year":"2008","unstructured":"Echahidi\u00a0N, Pibarot\u00a0P, O\u2019Hara\u00a0G, Mathieu\u00a0P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J\u00a0Am Coll Cardiol. 2008;51(8):793\u2013801.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2490_CR164","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","volume":"291","author":"JP Mathew","year":"2004","unstructured":"Mathew\u00a0JP, Fontes\u00a0ML, Tudor\u00a0IC, Ramsay\u00a0J, Duke\u00a0P, Mazer\u00a0CD, et\u00a0al. A\u00a0multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720\u20139.","journal-title":"JAMA"},{"issue":"5","key":"2490_CR165","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jacc.2003.11.023","volume":"43","author":"RP Villareal","year":"2004","unstructured":"Villareal\u00a0RP, Hariharan\u00a0R, Liu\u00a0BC, Kar\u00a0B, Lee\u00a0VV, Elayda\u00a0M, et\u00a0al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J\u00a0Am Coll Cardiol. 2004;43(5):742\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2490_CR166","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","volume":"124","author":"M Imazio","year":"2011","unstructured":"Imazio\u00a0M, Brucato\u00a0A, Ferrazzi\u00a0P, Rovere\u00a0ME, Gandino\u00a0A, Cemin\u00a0R, et\u00a0al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290\u20135.","journal-title":"Circulation"},{"issue":"10","key":"2490_CR167","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.2014.11026","volume":"312","author":"M Imazio","year":"2014","unstructured":"Imazio\u00a0M, Brucato\u00a0A, Ferrazzi\u00a0P, Pullara\u00a0A, Adler\u00a0Y, Barosi\u00a0A, et\u00a0al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS\u20112 randomized clinical trial. JAMA. 2014;312(10):1016\u201323.","journal-title":"JAMA"},{"key":"2490_CR168","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ahj.2016.05.006","volume":"178","author":"RA Tabbalat","year":"2016","unstructured":"Tabbalat\u00a0RA, Hamad\u00a0NM, Alhaddad\u00a0IA, Hammoudeh\u00a0A, Akasheh\u00a0BF, Khader\u00a0Y. Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial. Am Heart\u00a0J. 2016;178:102\u20137.","journal-title":"Am Heart J"},{"issue":"1","key":"2490_CR169","first-page":"4","volume":"107","author":"CS Zarpelon","year":"2016","unstructured":"Zarpelon\u00a0CS, Netto\u00a0MC, Jorge\u00a0JC, Fabris\u00a0CC, Desengrini\u00a0D, Jardim Mda\u00a0S, et\u00a0al. Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization. Arq Bras Cardiol. 2016;107(1):4\u20139.","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"2490_CR170","first-page":"363","volume":"9","author":"V Shvartz","year":"2022","unstructured":"Shvartz\u00a0V, Le\u00a0T, Enginoev\u00a0S, Sokolskaya\u00a0M, Ispiryan\u00a0A, Shvartz\u00a0E, et\u00a0al. Colchicine in Cardiac Surgery: The COCS Randomized Clinical Trial. J\u00a0Cardiovasc Dev Dis. 2022;9(10):363.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"3","key":"2490_CR171","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/FJC.0000000000001533","volume":"83","author":"FB Rivera","year":"2024","unstructured":"Rivera\u00a0FB, Whoy\u00a0CS, Aparece\u00a0JP, Jariyatamkitti\u00a0S, Mamas\u00a0MA. Efficacy and Safety of Colchicine for the Prevention of Postoperative Atrial Fibrillation Among Patients Undergoing Major Cardiothoracic Surgery: A\u00a0Meta-analysis and Meta-regression of Randomized Controlled Trials. J\u00a0Cardiovasc Pharmacol. 2024;83(3):265\u201370.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18","key":"2490_CR172","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","volume":"60","author":"S Deftereos","year":"2012","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Kossyvakis\u00a0C, Efremidis\u00a0M, Panagopoulou\u00a0V, Kaoukis\u00a0A, et\u00a0al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a\u00a0randomized controlled study. J\u00a0Am Coll Cardiol. 2012;60(18):1790\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2490_CR173","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","volume":"11","author":"S Deftereos","year":"2014","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Efremidis\u00a0M, Kossyvakis\u00a0C, Katsivas\u00a0A, Panagopoulou\u00a0V, et\u00a0al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11(4):620\u20138.","journal-title":"Heart Rhythm"},{"key":"2490_CR174","doi-asserted-by":"crossref","unstructured":"Egami Y, Nishino M, Shutta R, Makino N, Tanouchi J. Relation Between Colchicine and Epicardial Adipose Tissue Volume Surrounding Left Atrium in Atrial Fibrillation Recurrence After Ablation. Circulation. 2015;132s(3).","DOI":"10.1161\/circ.132.suppl_3.12012"},{"issue":"14","key":"2490_CR175","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.3390\/nu14142926","volume":"14","author":"MG Tarsitano","year":"2022","unstructured":"Tarsitano\u00a0MG, Pandozzi\u00a0C, Muscogiuri\u00a0G, Sironi\u00a0S, Pujia\u00a0A, Lenzi\u00a0A, et\u00a0al. Epicardial Adipose Tissue: A\u00a0Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation. Nutrients. 2022;14(14):2926.","journal-title":"Nutrients"},{"issue":"1","key":"2490_CR176","doi-asserted-by":"publisher","first-page":"e01238","DOI":"10.1161\/CIRCEP.123.012387","volume":"17","author":"AP Benz","year":"2024","unstructured":"Benz\u00a0AP, Amit\u00a0G, Connolly\u00a0SJ, Singh\u00a0J, Acosta-V\u00e9lez\u00a0JG, Conen\u00a0D, et\u00a0al. Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A\u00a0Randomized, Placebo-Controlled Trial. Circ Arrhythm Electrophysiol. 2024;17(1):e1238.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"2490_CR177","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/ejcts\/ezx422","volume":"53","author":"A Bessissow","year":"2018","unstructured":"Bessissow\u00a0A, Agzarian\u00a0J, Shargall\u00a0Y, Srinathan\u00a0S, Neary\u00a0J, Tandon\u00a0V, et\u00a0al. Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a\u00a0pilot randomized controlled study. Eur J Cardiothorac Surg. 2018;53(5):945\u201351.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10413","key":"2490_CR178","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(23)01689-6","volume":"402","author":"D Conen","year":"2023","unstructured":"Conen\u00a0D, Wang\u00a0KM, Popova\u00a0E, Chan\u00a0MTV, Landoni\u00a0G, Cata\u00a0JP, et\u00a0al. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. Lancet. 2023;402(10413):1627\u201335.","journal-title":"Lancet"},{"issue":"36","key":"2490_CR179","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M, Gardner\u00a0RS, Baumbach\u00a0A, B\u00f6hm\u00a0M, et\u00a0al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"5","key":"2490_CR180","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10741-010-9164-8","volume":"15","author":"BI Jugdutt","year":"2010","unstructured":"Jugdutt\u00a0BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010;15(5):401\u20135.","journal-title":"Heart Fail Rev"},{"key":"2490_CR181","unstructured":"BMSGPK. Herz-Kreislauf-Erkrankungen in \u00d6sterreich. 2020. https:\/\/www.sozialministerium.at\/dam\/jcr:ef1ec0fd-01a7-4047-9828-42ce906a2239\/Bericht__HKE_2020_2021_Mit_Titelbild.pdf. Zugegriffen: 11. Nov. 2024."},{"issue":"4","key":"2490_CR182","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pathophys.2018.04.003","volume":"25","author":"D Gabriel-Costa","year":"2018","unstructured":"Gabriel-Costa\u00a0D. The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology. 2018;25(4):277\u201384.","journal-title":"Pathophysiology"},{"issue":"1","key":"2490_CR183","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick\u00a0SA, Epelman\u00a0S. Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res. 2016;119(1):159\u201376.","journal-title":"Circ Res"},{"issue":"9608","key":"2490_CR184","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(08)60134-8","volume":"371","author":"G Torre-Amione","year":"2008","unstructured":"Torre-Amione\u00a0G, Anker\u00a0SD, Bourge\u00a0RC, Colucci\u00a0WS, Greenberg\u00a0BH, Hildebrandt\u00a0P, et\u00a0al. Results of a\u00a0non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a\u00a0placebo-controlled randomised trial. Lancet. 2008;371(9608):228\u201336.","journal-title":"Lancet"},{"issue":"2","key":"2490_CR185","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","volume":"2","author":"S Deftereos","year":"2014","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Panagopoulou\u00a0V, Bouras\u00a0G, Raisakis\u00a0K, Kossyvakis\u00a0C, et\u00a0al. Anti-inflammatory treatment with colchicine in stable chronic heart failure: a\u00a0prospective, randomized study. JACC Heart Fail. 2014;2(2):131\u20137.","journal-title":"JACC Heart Fail"},{"key":"2490_CR186","unstructured":"DEGAM. S3-Leitlinie Schlaganfall. 2020. https:\/\/register.awmf.org\/assets\/guidelines\/053-011l_S3_Schlaganfall_2023-05.pdf. Zugegriffen: 11. Nov. 2024."},{"issue":"12","key":"2490_CR187","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers\u00a0WJ, Rabinstein\u00a0AA, Ackerson\u00a0T, Adeoye\u00a0OM, Bambakidis\u00a0NC, Becker\u00a0K, et\u00a0al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A\u00a0Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013e418.","journal-title":"Stroke"},{"issue":"10","key":"2490_CR188","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/10600280211073009","volume":"56","author":"M Kamarova","year":"2022","unstructured":"Kamarova\u00a0M, Baig\u00a0S, Patel\u00a0H, Monks\u00a0K, Wasay\u00a0M, Ali\u00a0A, et\u00a0al. Antiplatelet Use in Ischemic Stroke. Ann Pharmacother. 2022;56(10):1159\u201373.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2490_CR189","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/23969873231174942","volume":"8","author":"N Silimon","year":"2023","unstructured":"Silimon\u00a0N, Drop\u00a0B, Cl\u00e9nin\u00a0L, Nedeltchev\u00a0K, Kahles\u00a0T, Tarnutzer\u00a0AA, et\u00a0al. Ischaemic stroke despite antiplatelet therapy: Causes and outcomes. Eur Stroke\u00a0J. 2023;8(3):692\u2013702.","journal-title":"Eur Stroke J"},{"issue":"8","key":"2490_CR190","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2014.80","volume":"11","author":"JM Tarkin","year":"2014","unstructured":"Tarkin\u00a0JM, Joshi\u00a0FR, Rudd\u00a0JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014;11(8):443\u201357.","journal-title":"Nat Rev Cardiol"},{"issue":"14","key":"2490_CR191","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20160090","volume":"130","author":"S Robertson","year":"2016","unstructured":"Robertson\u00a0S, Mart\u00ednez\u00a0GJ, Payet\u00a0CA, Barraclough\u00a0JY, Celermajer\u00a0DS, Bursill\u00a0C, et\u00a0al. Colchicine therapy in acute coronary syndrome patients acts on caspase\u20111 to suppress NLRP3 inflammasome monocyte activation. Clin Sci. 2016;130(14):1237\u201346.","journal-title":"Clin Sci"},{"issue":"3","key":"2490_CR192","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.clinthera.2019.02.003","volume":"41","author":"C Khandkar","year":"2019","unstructured":"Khandkar\u00a0C, Vaidya\u00a0K, Patel\u00a0S. Colchicine for Stroke Prevention: A\u00a0Systematic Review and Meta-analysis. Clin Ther. 2019;41(3):582\u2013590.e3.","journal-title":"Clin Ther"},{"issue":"3","key":"2490_CR193","doi-asserted-by":"publisher","first-page":"105580","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105580","volume":"30","author":"E Yilmaz","year":"2021","unstructured":"Yilmaz\u00a0E, Akay\u00a0KH. The Efficacy of Colchicine on Carotid Intima-Media Thickness: A\u00a0Prospective Comparative Study. J\u00a0Stroke Cerebrovasc Dis. 2021;30(3):105580.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2490_CR194","doi-asserted-by":"publisher","first-page":"106288","DOI":"10.1016\/j.ejps.2022.106288","volume":"178","author":"B Yuan","year":"2022","unstructured":"Yuan\u00a0B, Meng\u00a0X, Wang\u00a0A, Niu\u00a0S, Xie\u00a0X, Jing\u00a0J, et\u00a0al. Effect of different doses of colchicine on high sensitivity C\u2011reactive protein in patients with acute minor stroke or transient ischemic attack: A\u00a0pilot randomized controlled trial. Eur J Pharm Sci. 2022;178:106288.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"2490_CR195","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/jpm11090935","volume":"11","author":"CH Liu","year":"2021","unstructured":"Liu\u00a0CH, Lin\u00a0YS, Sung\u00a0PS, Wei\u00a0YC, Chang\u00a0TY, Lee\u00a0TH, et\u00a0al. Colchicine Use and Risks of Stroke Recurrence in Acute Non-Cardiogenic Ischemic Stroke Patients: A\u00a0Population-Based Cohort Study. J\u00a0Pers Med. 2021;11(9):935.","journal-title":"J Pers Med"},{"issue":"3","key":"2490_CR196","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/bc.bc_24_21","volume":"7","author":"A Al-Atta","year":"2021","unstructured":"Al-Atta\u00a0A, Kuzemczak\u00a0M, Alkhalil\u00a0M. Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials. Brain Circ. 2021;7(3):187\u201393.","journal-title":"Brain Circ"},{"issue":"24","key":"2490_CR197","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos\u00a0K, Spiliopoulos\u00a0S, Kitrou\u00a0P, Krokidis\u00a0M, Karnabatidis\u00a0D. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A\u00a0Systematic Review and Meta-Analysis of Randomized Controlled Trials. J\u00a0Am Heart Assoc. 2018;7(24):e11245.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2490_CR198","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11239-022-02659-9","volume":"54","author":"CXY Goh","year":"2022","unstructured":"Goh\u00a0CXY, Tan\u00a0YK, Tan\u00a0CH, Leow\u00a0AST, Ho\u00a0JSY, Tan\u00a0NHW, et\u00a0al. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a\u00a0systematic review and meta-analysis. J\u00a0Thromb Thrombolysis. 2022;54(1):183\u201390.","journal-title":"J Thromb Thrombolysis"},{"key":"2490_CR199","doi-asserted-by":"publisher","first-page":"8646351","DOI":"10.1155\/2024\/8646351","volume":"2024","author":"E Akl","year":"2024","unstructured":"Akl\u00a0E, Sahami\u00a0N, Labos\u00a0C, Genest\u00a0J, Zgheib\u00a0A, Piazza\u00a0N, et\u00a0al. Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease. J\u00a0Interv Cardiol. 2024;2024:8646351.","journal-title":"J Interv Cardiol"},{"issue":"10448","key":"2490_CR200","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","volume":"404","author":"P Kelly","year":"2024","unstructured":"Kelly\u00a0P, Lemmens\u00a0R, Weimar\u00a0C, Walsh\u00a0C, Purroy\u00a0F, Barber\u00a0M, et\u00a0al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a\u00a0randomised controlled trial. Lancet. 2024;404(10448):125\u201333.","journal-title":"Lancet"},{"issue":"7","key":"2490_CR201","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/17474930231172312","volume":"18","author":"Y Wang","year":"2023","unstructured":"Wang\u00a0Y, Li\u00a0J, Johnston\u00a0SC, Hankey\u00a0GJ, Easton\u00a0JD, Meng\u00a0X, et\u00a0al. Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a\u00a0multicenter randomized placebo-controlled trial. Int J Stroke. 2023;18(7):873\u20138.","journal-title":"Int J Stroke"},{"issue":"2","key":"2490_CR202","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann\u00a0FJ, Sousa-Uva\u00a0M, Ahlsson\u00a0A, Alfonso\u00a0F, Banning\u00a0AP, Benedetto\u00a0U, et\u00a0al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart\u00a0J. 2019;40(2):87\u2013165.","journal-title":"Eur Heart J"},{"issue":"10","key":"2490_CR203","doi-asserted-by":"publisher","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","volume":"8","author":"D Buccheri","year":"2016","unstructured":"Buccheri\u00a0D, Piraino\u00a0D, Andolina\u00a0G, Cortese\u00a0B. Understanding and managing in-stent restenosis: a\u00a0review of clinical data, from pathogenesis to treatment. J\u00a0Thorac Dis. 2016;8(10):E1150\u2013E62.","journal-title":"J Thorac Dis"},{"issue":"2","key":"2490_CR204","first-page":"211","volume":"5","author":"MS Lee","year":"2016","unstructured":"Lee\u00a0MS, Banka\u00a0G. In-stent Restenosis. Interv Cardiol Clin. 2016;5(2):211\u201320.","journal-title":"Interv Cardiol Clin"},{"issue":"12","key":"2490_CR205","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/0002-9149(94)90806-0","volume":"73","author":"C Le Feuvre","year":"1994","unstructured":"Le Feuvre\u00a0C, Bonan\u00a0R, Lesp\u00e9rance\u00a0J, Gosselin\u00a0G, Joyal\u00a0M, Cr\u00e9peau\u00a0J. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol. 1994;73(12):840\u20134.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2490_CR206","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ahj.2005.05.001","volume":"151","author":"P Agostoni","year":"2006","unstructured":"Agostoni\u00a0P, Valgimigli\u00a0M, Biondi-Zoccai\u00a0GG, Abbate\u00a0A, Garcia Garcia\u00a0HM, Anselmi\u00a0M, et\u00a0al. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a\u00a0systematic overview of randomized trials in light of the drug-eluting stent era. Am Heart\u00a0J. 2006;151(3):682\u20139.","journal-title":"Am Heart J"},{"issue":"14","key":"2490_CR207","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses\u00a0JW, Leon\u00a0MB, Popma\u00a0JJ, Fitzgerald\u00a0PJ, Holmes\u00a0DR, O\u2019Shaughnessy\u00a0C, et\u00a0al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a\u00a0native coronary artery. N\u00a0Engl J Med. 2003;349(14):1315\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"2490_CR208","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone\u00a0GW, Ellis\u00a0SG, Cox\u00a0DA, Hermiller\u00a0J, O\u2019Shaughnessy\u00a0C, Mann\u00a0JT, et\u00a0al. A\u00a0polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N\u00a0Engl J Med. 2004;350(3):221\u201331.","journal-title":"N Engl J Med"},{"issue":"4","key":"2490_CR209","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino\u00a0G, Colombo\u00a0A, Camaj\u00a0A, Yasumura\u00a0K, Mehran\u00a0R, Stone\u00a0GW, et\u00a0al. Coronary In-Stent Restenosis: JACC State-of-the-Art Review. J\u00a0Am Coll Cardiol. 2022;80(4):348\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2490_CR210","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1067\/mhj.2003.16","volume":"145","author":"M Almagor","year":"2003","unstructured":"Almagor\u00a0M, et\u00a0al. Am Heart\u00a0J. 2003;145(2):248\u201353.","journal-title":"Am Heart J"},{"issue":"6","key":"2490_CR211","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/CIRCINTERVENTIONS.112.972182","volume":"5","author":"J Herrmann","year":"2012","unstructured":"Herrmann\u00a0J, Lennon\u00a0RJ, Barsness\u00a0GW, Sandhu\u00a0GS, Gulati\u00a0R, Best\u00a0PJ, et\u00a0al. High sensitivity C\u2011reactive protein and outcomes following percutaneous coronary intervention in contemporary practice. Circ Cardiovasc Interv. 2012;5(6):783\u201390.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2490_CR212","doi-asserted-by":"publisher","first-page":"e004981","DOI":"10.1161\/CIRCINTERVENTIONS.117.004981","volume":"10","author":"B Shah","year":"2017","unstructured":"Shah\u00a0B, Baber\u00a0U, Pocock\u00a0SJ, Krucoff\u00a0MW, Ariti\u00a0C, Gibson\u00a0CM, et\u00a0al. White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). Circ Cardiovasc Interv. 2017;10(9):e4981.","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"2490_CR213","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","volume":"19","author":"JH O\u2019Keefe Jr","year":"1992","unstructured":"O\u2019Keefe\u00a0JH Jr, McCallister\u00a0BD, Bateman\u00a0TM, Kuhnlein\u00a0DL, Ligon\u00a0RW, Hartzler\u00a0GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J\u00a0Am Coll Cardiol. 1992;19(7):1597\u2013600.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2490_CR214","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0002-9149(99)80334-8","volume":"76","author":"M Freed","year":"1995","unstructured":"Freed\u00a0M, Safian\u00a0RD, O\u2019Neill\u00a0WW, Safian\u00a0M, Jones\u00a0D, Grines\u00a0CL. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;76(16):1185\u20138.","journal-title":"Am J Cardiol"},{"issue":"16","key":"2490_CR215","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","volume":"61","author":"S Deftereos","year":"2013","unstructured":"Deftereos\u00a0S, Giannopoulos\u00a0G, Raisakis\u00a0K, Kossyvakis\u00a0C, Kaoukis\u00a0A, Panagopoulou\u00a0V, et\u00a0al. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J\u00a0Am Coll Cardiol. 2013;61(16):1679\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2490_CR216","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.amjcard.2015.02.036","volume":"115","author":"G Giannopoulos","year":"2015","unstructured":"Giannopoulos\u00a0G, Angelidis\u00a0C, Kouritas\u00a0VK, Dedeilias\u00a0P, Filippatos\u00a0G, Cleman\u00a0MW, et\u00a0al. Usefulness of colchicine to reduce perioperative myocardial damage in patients who underwent on-pump coronary artery bypass grafting. Am J Cardiol. 2015;115(10):1376\u201381.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2490_CR217","doi-asserted-by":"publisher","first-page":"e009992","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","volume":"14","author":"J Cole","year":"2021","unstructured":"Cole\u00a0J, Htun\u00a0N, Lew\u00a0R, Freilich\u00a0M, Quinn\u00a0S, Layland\u00a0J. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial. Circ Cardiovasc Interv. 2021;14(5):e9992.","journal-title":"Circ Cardiovasc Interv"},{"key":"2490_CR218","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.amjcard.2023.07.029","volume":"204","author":"B Shah","year":"2023","unstructured":"Shah\u00a0B, Smilowitz\u00a0NR, Xia\u00a0Y, Feit\u00a0F, Katz\u00a0SD, Zhong\u00a0J, et\u00a0al. Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial. Am J Cardiol. 2023;204:26\u20138.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2490_CR219","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/fca-2020-0161","volume":"17","author":"C Correa-Sadouet","year":"2021","unstructured":"Correa-Sadouet\u00a0C, Rodr\u00edguez-Granillo\u00a0AM, Gallardo\u00a0C, Mieres\u00a0J, Fontana\u00a0L, Curotto\u00a0MV, et\u00a0al. Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention. Future Cardiol. 2021;17(4):539\u201347.","journal-title":"Future Cardiol"},{"issue":"6","key":"2490_CR220","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco\u00a0A, De Virgilio\u00a0A, Ralli\u00a0M, Ciofalo\u00a0A, Mancini\u00a0P, Attanasio\u00a0G, et\u00a0al. Beh\u00e7et\u2019s disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567\u201375.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2490_CR221","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1573397115666190415142426","volume":"16","author":"IG Nieto","year":"2020","unstructured":"Nieto\u00a0IG, Alabau\u00a0JLC. Immunopathogenesis of Beh\u00e7et Disease. Curr Rheumatol Rev. 2020;16(1):12\u201320.","journal-title":"Curr Rheumatol Rev"},{"issue":"10431","key":"2490_CR222","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","volume":"403","author":"G Emmi","year":"2024","unstructured":"Emmi\u00a0G, Bettiol\u00a0A, Hatemi\u00a0G, Prisco\u00a0D. Beh\u00e7et\u2019s syndrome. Lancet. 2024;403(10431):1093\u2013108.","journal-title":"Lancet"},{"issue":"2","key":"2490_CR223","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clinthera.2023.01.004","volume":"45","author":"Z Wang","year":"2023","unstructured":"Wang\u00a0Z, Zu\u00a0X, Xiong\u00a0S, Mao\u00a0R, Qiu\u00a0Y, Chen\u00a0B, et\u00a0al. The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease. Clin Ther. 2023;45(2):162\u201376.","journal-title":"Clin Ther"},{"issue":"3","key":"2490_CR224","first-page":"399","volume":"65","author":"E Aktulga","year":"1980","unstructured":"Aktulga\u00a0E, Alta\u00e7\u00a0M, M\u00fcft\u00fcoglu\u00a0A, Ozyazgan\u00a0Y, Pazarli\u00a0H, T\u00fcz\u00fcn\u00a0Y, et\u00a0al. A\u00a0double blind study of colchicine in Beh\u00e7et\u2019s disease. Haematologica. 1980;65(3):399\u2013402.","journal-title":"Haematologica"},{"issue":"11","key":"2490_CR225","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","volume":"44","author":"S Yurdakul","year":"2001","unstructured":"Yurdakul\u00a0S, Mat\u00a0C, T\u00fcz\u00fcn\u00a0Y, Ozyazgan\u00a0Y, Hamuryudan\u00a0V, Uysal\u00a0O, et\u00a0al. A\u00a0double-blind trial of colchicine in Beh\u00e7et\u2019s syndrome. Arthritis Rheum. 2001;44(11):2686\u201392.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2490_CR226","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","volume":"19","author":"F Davatchi","year":"2009","unstructured":"Davatchi\u00a0F, Sadeghi Abdollahi\u00a0B, Tehrani Banihashemi\u00a0A, Shahram\u00a0F, Nadji\u00a0A, Shams\u00a0H, et\u00a0al. Colchicine versus placebo in Beh\u00e7et\u2019s disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol. 2009;19(5):542\u20139.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"2490_CR227","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi\u00a0G, Christensen\u00a0R, Bang\u00a0D, Bodaghi\u00a0B, Celik\u00a0AF, Fortune\u00a0F, et\u00a0al. 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann Rheum Dis. 2018;77(6):808\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2490_CR228","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/BOR.0000000000000563","volume":"31","author":"M Caproni","year":"2019","unstructured":"Caproni\u00a0M, Verdelli\u00a0A. An update on the nomenclature for cutaneous vasculitis. Curr Opin Rheumatol. 2019;31(1):46\u201352.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"2490_CR229","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.abd.2020.01.003","volume":"95","author":"TCAB Morita","year":"2020","unstructured":"Morita\u00a0TCAB, Tr\u00e9s\u00a0GFS, Criado\u00a0RFJ, Sotto\u00a0MN, Criado\u00a0PR. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis\u2014part I. An Bras Dermatol. 2020;95(3):355\u201371.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"2490_CR230","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11739-021-02688-x","volume":"16","author":"P Fraticelli","year":"2021","unstructured":"Fraticelli\u00a0P, Benfaremo\u00a0D, Gabrielli\u00a0A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021;16(4):831\u201341.","journal-title":"Intern Emerg Med"},{"issue":"2 Pt 1","key":"2490_CR231","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","volume":"13","author":"JP Callen","year":"1985","unstructured":"Callen\u00a0JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J\u00a0Am Acad Dermatol. 1985;13(2 Pt 1):193\u2013200.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"2490_CR232","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/archderm.1995.01690240061009","volume":"131","author":"G Sais","year":"1995","unstructured":"Sais\u00a0G, Vidaller\u00a0A, Jucgl\u00e0\u00a0A, Gallardo\u00a0F, Peyr\u00ed\u00a0J. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a\u00a0prospective, randomized controlled trial. Arch Dermatol. 1995;131(12):1399\u2013402.","journal-title":"Arch Dermatol"},{"key":"2490_CR233","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2019.00414","volume":"10","author":"MS Heath","year":"2019","unstructured":"Heath\u00a0MS, Ortega-Loayza\u00a0AG. Insights Into the Pathogenesis of Sweet\u2019s Syndrome. Front Immunol. 2019;10:414.","journal-title":"Front Immunol"},{"key":"2490_CR234","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen\u00a0PR. Sweet\u2019s syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2490_CR235","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","volume":"107","author":"CD Villarreal-Villarreal","year":"2016","unstructured":"Villarreal-Villarreal\u00a0CD, Ocampo-Candiani\u00a0J, Villarreal-Mart\u00ednez\u00a0A. Sweet Syndrome: A\u00a0Review and Update. Actas Dermosifiliogr. 2016;107(5):369\u201378.","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"2490_CR236","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40257-022-00673-4","volume":"23","author":"TP Joshi","year":"2022","unstructured":"Joshi\u00a0TP, Friske\u00a0SK, Hsiou\u00a0DA, Duvic\u00a0M. New Practical Aspects of Sweet Syndrome. Am J Clin Dermatol. 2022;23(3):301\u201318.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"2490_CR237","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0190-9622(98)70266-X","volume":"39","author":"AS Giasuddin","year":"1998","unstructured":"Giasuddin\u00a0AS, El-Orfi\u00a0AH, Ziu\u00a0MM, El-Barnawi\u00a0NY. Sweet\u2019s syndrome: is the pathogenesis mediated by helper T\u00a0cell type\u00a01 cytokines? J\u00a0Am Acad Dermatol. 1998;39(6):940\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2490_CR238","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/ajd.12795","volume":"59","author":"KP Robinson","year":"2018","unstructured":"Robinson\u00a0KP, Chan\u00a0JJ. Colchicine in dermatology: A\u00a0review. Australas J Dermatol. 2018;59(4):278\u201385.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"2490_CR239","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2133.1981.tb00785.x","volume":"105","author":"S Suehisa","year":"1981","unstructured":"Suehisa\u00a0S, Tagami\u00a0H. Treatment of acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome) with colchicine. Br J Dermatol. 1981;105(4):483.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2490_CR240","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2133.1983.tb04584.x","volume":"108","author":"S Suehisa","year":"1983","unstructured":"Suehisa\u00a0S, Tagami\u00a0H, Inoue\u00a0F, Matsumoto\u00a0K, Yoshikuni\u00a0K. Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome). Br J Dermatol. 1983;108(1):99\u2013101.","journal-title":"Br J Dermatol"},{"issue":"8","key":"2490_CR241","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/archderm.1993.01680290138029","volume":"129","author":"J Pouchot","year":"1993","unstructured":"Pouchot\u00a0J, Bourgeois-Droin\u00a0C, Vinceneu\u00a0P, Barge\u00a0J, Brun\u00a0P, Granier\u00a0F, et\u00a0al. Sweet\u2019s syndrome and mediastinal lymphadenopathy due to sarcoidosis: three cases of a\u00a0new association. Arch Dermatol. 1993;129(8):1062\u20134.","journal-title":"Arch Dermatol"},{"issue":"3","key":"2490_CR242","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4065\/70.3.234","volume":"70","author":"DL Fett","year":"1995","unstructured":"Fett\u00a0DL, Gibson\u00a0LE, Su\u00a0WP. Sweet\u2019s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70(3):234\u201340.","journal-title":"Mayo Clin Proc"},{"key":"2490_CR243","first-page":"702","volume":"15","author":"O Boudghene-Stambouli","year":"1996","unstructured":"Boudghene-Stambouli\u00a0O, Merad-Boudia\u00a0A. Dermatose aigue febrile neutrophilique. Aspect clinique, evolutif et therapeutique. A\u00a0propos de 55\u00a0observations. Nouv Dermatol. 1996;15:702\u20136.","journal-title":"Nouv Dermatol"},{"issue":"4","key":"2490_CR244","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.1997.tb03796.x","volume":"137","author":"JF Bourke","year":"1997","unstructured":"Bourke\u00a0JF, Keohane\u00a0S, Long\u00a0CC, Kemmett\u00a0D, Davies\u00a0M, Zaki\u00a0I, et\u00a0al. Sweet\u2019s syndrome and malignancy in the U.K. Br J Dermatol. 1997;137(4):609\u201313.","journal-title":"Br J Dermatol"},{"issue":"3","key":"2490_CR245","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1365-2133.1999.02747.x","volume":"140","author":"H Maillard","year":"1999","unstructured":"Maillard\u00a0H, Leclech\u00a0C, Peria\u00a0P, Avenel-Audran\u00a0M, Verret\u00a0JL. Colchicine for Sweet\u2019s syndrome. A\u00a0study of 20\u00a0cases. Br J Dermatol. 1999;140(3):565\u20136.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2490_CR246","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1067\/mjd.2002.121028","volume":"47","author":"S Ritter","year":"2002","unstructured":"Ritter\u00a0S, George\u00a0R, Serwatka\u00a0LM, Elston\u00a0DM. Long-term suppression of chronic Sweet\u2019s syndrome with colchicine. J\u00a0Am Acad Dermatol. 2002;47(2):323\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 1","key":"2490_CR247","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.lpm.2006.07.010","volume":"36","author":"A Masmoudi","year":"2007","unstructured":"Masmoudi\u00a0A, Chaaben\u00a0H, Hamdouni\u00a0K, Boudaya\u00a0S, Bouassida\u00a0S, Turki\u00a0H, et\u00a0al. Sweet syndrome: retrospective study of 54\u00a0cases. Presse Med. 2007;36(3 Pt 1):419\u201324.","journal-title":"Presse Med"},{"issue":"3","key":"2490_CR248","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2133.2006.07677.x","volume":"156","author":"CY Neoh","year":"2007","unstructured":"Neoh\u00a0CY, Tan\u00a0AW, Ng\u00a0SK. Sweet\u2019s syndrome: a\u00a0spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007;156(3):480\u20135.","journal-title":"Br J Dermatol"},{"issue":"6","key":"2490_CR249","doi-asserted-by":"publisher","first-page":"e15171","DOI":"10.1111\/dth.15171","volume":"34","author":"S Chiewchanvit","year":"2021","unstructured":"Chiewchanvit\u00a0S, Jamjanya\u00a0S, Rattanathammethee\u00a0T, Mahanupab\u00a0P, Tovanabutra\u00a0N, Chuamanochan\u00a0M. Bullous Sweet syndrome in a\u00a0patient with acute myeloid leukemia treated with midostaurin: Rapid response to acitretin and colchicine\u2014A case report. Dermatol Ther. 2021;34(6):e15171.","journal-title":"Dermatol Ther"},{"issue":"11","key":"2490_CR250","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.clinthera.2023.09.021","volume":"45","author":"S Jansen","year":"2023","unstructured":"Jansen\u00a0S, de Borst\u00a0GJ, Hinchliffe\u00a0R, Teraa\u00a0M. Peripheral Artery Disease: Underappreciated Impact and Residual Cardiovascular Risk Despite Revascularization. Clin Ther. 2023;45(11):1019\u201322.","journal-title":"Clin Ther"},{"issue":"3","key":"2490_CR251","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.108.846519","volume":"120","author":"SR Preis","year":"2009","unstructured":"Preis\u00a0SR, Pencina\u00a0MJ, Hwang\u00a0SJ, D\u2019Agostino\u00a0RB Sr, Savage\u00a0PJ, Levy\u00a0D, et\u00a0al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation. 2009;120(3):212\u201320.","journal-title":"Circulation"},{"issue":"2","key":"2490_CR252","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed\u00a0G, Aoun\u00a0L, Bou Zerdan\u00a0M, Allam\u00a0S, Bou Zerdan\u00a0M, Bouferraa\u00a0Y, et\u00a0al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2490_CR253","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0939-4753(04)80048-6","volume":"14","author":"K Esposito","year":"2004","unstructured":"Esposito\u00a0K, Giugliano\u00a0D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14(5):228\u201332.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"16","key":"2490_CR254","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson\u00a0GK. Inflammation, atherosclerosis, and coronary artery disease. N\u00a0Engl J Med. 2005;352(16):1685\u201395.","journal-title":"N Engl J Med"},{"issue":"5","key":"2490_CR255","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa\u00a0T, Takahama\u00a0M, Kozaki\u00a0T, Lee\u00a0H, Zou\u00a0J, Saitoh\u00a0T, et\u00a0al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454\u201360.","journal-title":"Nat Immunol"},{"key":"2490_CR256","doi-asserted-by":"publisher","first-page":"1244529","DOI":"10.3389\/fcvm.2023.1244529","volume":"10","author":"N Mohammadnia","year":"2023","unstructured":"Mohammadnia\u00a0N, Los\u00a0J, Opstal\u00a0TSJ, Fiolet\u00a0ATL, Eikelboom\u00a0JW, Mosterd\u00a0A, et\u00a0al. Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial. Front Cardiovasc Med. 2023;10:1244529.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2490_CR257","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000527411","volume":"7","author":"Y Miwa","year":"2022","unstructured":"Miwa\u00a0Y, Mutoh\u00a0A, Morimoto\u00a0T, Ikehara\u00a0Y, Yasu\u00a0T, Koba\u00a0S, et\u00a0al. Effects of Low-Dose Colchicine on Serum High-Sensitivity C\u2011Reactive Protein Level in Coronary Artery Disease Patients with Type\u00a02 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a\u00a0Randomized, Double-Blind, Placebo-Controlled, Phase\u00a02, Dose-Finding Study. Biomed Hub. 2022;7(3):156\u201364.","journal-title":"Biomed Hub"},{"issue":"8","key":"2490_CR258","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5694\/mja2.51488","volume":"216","author":"SM Nidorf","year":"2022","unstructured":"Nidorf\u00a0SM, Layland\u00a0J, Robinson\u00a0PC, Patel\u00a0S, Psaltis\u00a0PJ, Thompson\u00a0PL. Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease. Med J Aust. 2022;216(8):385\u20137.","journal-title":"Med J Aust"},{"key":"2490_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2022.12.026","volume":"372","author":"TSJ Opstal","year":"2023","unstructured":"Opstal\u00a0TSJ, Nidorf\u00a0SM, Fiolet\u00a0ATL, Eikelboom\u00a0JW, Mosterd\u00a0A, Bax\u00a0WA, et\u00a0al. Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2\u00a0trial. Int J Cardiol. 2023;372:1\u20135.","journal-title":"Int J Cardiol"},{"issue":"5","key":"2490_CR260","doi-asserted-by":"publisher","first-page":"e15162","DOI":"10.1111\/1756-185X.15162","volume":"27","author":"PY Chen","year":"2024","unstructured":"Chen\u00a0PY, Tseng\u00a0CC, Lee\u00a0YT, Yip\u00a0HT, Chang\u00a0R, Wei\u00a0JC. Association between colchicine use and the risk of dementia among patients with gout: A\u00a0nationwide retrospective cohort study. Int J Rheum Dis. 2024;27(5):e15162.","journal-title":"Int J Rheum Dis"},{"issue":"18","key":"2490_CR261","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","volume":"45","author":"SM Nidorf","year":"2024","unstructured":"Nidorf\u00a0SM, Ben-Chetrit\u00a0E, Ridker\u00a0PM. Low-dose colchicine for atherosclerosis: long-term safety. Eur Heart\u00a0J. 2024;45(18):1596\u2013601.","journal-title":"Eur Heart J"},{"issue":"7 Pt 2","key":"2490_CR262","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacep.2023.01.037","volume":"9","author":"S Mohanty","year":"2023","unstructured":"Mohanty\u00a0S, Mohanty\u00a0P, Kessler\u00a0D, Gianni\u00a0C, Baho\u00a0KK, Morris\u00a0T, et\u00a0al. Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation. JACC Clin Electrophysiol. 2023;9(7 Pt 2):1051\u20139.","journal-title":"JACC Clin Electrophysiol"},{"issue":"7 Pt 2","key":"2490_CR263","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jacep.2023.02.003","volume":"9","author":"AS Ahmed","year":"2023","unstructured":"Ahmed\u00a0AS, Miller\u00a0J, Foreman\u00a0J, Golden\u00a0K, Shah\u00a0A, Field\u00a0J, et\u00a0al. Prophylactic Colchicine After Radiofrequency Ablation of Atrial Fibrillation: The PAPERS Study. JACC Clin Electrophysiol. 2023;9(7 Pt 2):1060\u20136.","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-024-02490-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:28:04Z","timestamp":1738830484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-024-02490-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":263,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2490"],"URL":"https:\/\/doi.org\/10.1007\/s00508-024-02490-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"29 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Lunzer, G.\u00a0Delle-Karth, M.\u00a0Zeitlinger, M.\u00a0Prager und L.M.\u00a0Pracher geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}